newsfilter
← Latest News
GlobeNewswire·

Aprea Therapeutics to Present at H.C. Wainwright Global Investment Conference

DOYLESTOWN, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (NASDAQ:APRE) ("Aprea", or the "Company"), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific